Mirum Pharmaceuticals Inc is a biopharmaceutical company aimed at the development and commercialisation of novel therapies for debilitating liver diseases. The company works on a global scale, principally in the US and Europe.
Operating in the healthcare sector, Mirum Pharmaceuticals Inc offers a broad spectrum of services and advancements. The company is focused on rare paediatric diseases and is particularly known for its work on cholestatic liver diseases. Although independent, Mirum Pharmaceuticals Inc collaborates with other organisations to further its research and bring new treatments to market.
Track the MIRM share price on your eToro watchlist.